Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,otherCurrentAssets,retainedEarnings,otherLiab,goodWill,treasuryStock,otherAssets,cash,totalCurrentLiabilities,shortLongTermDebt,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,longTermInvestments,shortTermInvestments,netReceivables,longTermDebt,inventory,accountsPayable,investments,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,changeInCash,repurchaseOfStock,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,changeToInventory,changeToAccountReceivables,otherCashflowsFromFinancingActivities,changeToNetincome,capitalExpenditures,issuanceOfStock,WC,language,region,quoteType,triggerable,quoteSourceName,currency,priceHint,exchange,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,exchangeDataDelayedBy,shortName,marketState,market,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,trailingPE,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,forwardPE,epsTrailingTwelveMonths,epsForward,epsCurrentYear,priceEpsCurrentYear,bookValue,fiftyDayAverage,fiftyDayAverageChange,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,esgPopulated,tradeable,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,"Shares Short (Aug 12, 2021) 4","Short Ratio (Aug 12, 2021) 4","Short % of Float (Aug 12, 2021) 4","Short % of Shares Outstanding (Aug 12, 2021) 4","Shares Short (prior month Jul 14, 2021) 4",Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,compensationRisk,auditRisk,longBusinessSummary,city,phone,state,shareHolderRightsRisk,compensationAsOfEpochDate,governanceEpochDate,boardRisk,country,website,maxAge,overallRisk,address1,industry
t0,DVA,-5828369000,106200000,,,432340000,1611257000,293820000,298091000,951233000,483453000,483453000,,-71947000,,,,81309000,2916510000,2433057000,1965277000,-51113000,,351031000,293820000,162484000,523038000,14921274000,1277780000,849140000,17810311000,111000,162846000,1383760000,1009648000,6943665000,-629129000,89058000,1043632000,2386040000,184435000,-65899000,6350920000,3978586000,285598000,36701000,2550678000,8496728000,115369000,376264000,-3023000.0,28114000.0,-159333000.0,-51992000.0,-381730000.0,26154000.0,145438000.0,-285338000.0,6769000.0,679732000.0,169689000.0,2033000.0,107103000.0,-44400000.0,104785000.0,-149525000.0,,1592546000,en-US,US,EQUITY,True,Nasdaq Real Time Price,USD,2,NYQ,128.33,1630506454,-2.4400024,130.97,130.97,128.33,67701,0,DaVita Inc.,REGULAR,us_market,-1.8658731,128.33 - 130.97,130.77,128.81,128.95,8,9,finmb_35644,NYSE,DaVita Inc.,USD,591603,421883,47.480003,0.5872604,80.85 - 136.48,-8.149994,-0.059715666,80.85,136.48,1619712309,1635332340,1635768000,19.837688,0.015434107,117.63196,10.698044,0.09094504,13.367708,6.469,9.6,9.22,13.918654,11.656,126.37945,1.9505539,13628646400,11.00978,15,America/New_York,EDT,-14400000,False,False,1.27,,,136.48,80.85,126.38,117.63,591.6k,421.88k,106.2M,,101.73M,2.97%,90.28%,2.46M,3.7,3.60%,2.35%,2.25M,,,,,,0.00%,,,2:1,"Sep 08, 2013","Dec 30, 2020","Jun 29, 2021",7.47%,14.98%,5.84%,34.47%,11.57B,103.40,1.30%,3.56B,2.39B,883.3M,6.47,45.70%,1.08B,10.31,12.09B,418.56,1.67,11.66,1.8B,602.51M,Value,80202,Healthcare,67000,9,6,"DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services; vascular access services; clinical research programs; physician services; and comprehensive care services. As of December 31, 2020, it provided dialysis and administrative services in the United States through a network of 2,816 outpatient dialysis centers serving approximately 204,200 patients; and operated 321 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 36,700 patients. Further, the company provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.",Denver,720 631 2100,CO,2,1609372800,1625097600,2,United States,http://www.davita.com,86400,6,2000 16th Street,Medical Care Facilities
t-1,DVA,-5793809000,106200000,,,376756000,1534269000,237403000,281426000,881671000,434544000,434544000,,-65637000,,,,85211000,2820001000,2385457000,1938330000,-57788000,,291545000,237403000,150706000,603172000,14864893000,1248106000,875020000,17647268000,110000,176835000,1089940000,981093000,6891209000,-445116000,81358000,884205000,2314724000,168191000,-122783000,6358734000,3866681000,298580000,11060000,2604494000,8540441000,116322000,348105000,7878000.0,-75504000.0,-124366000.0,908671000.0,537278000.0,-103918000.0,559250000.0,-318774000.0,-7966000.0,154304000.0,165701000.0,-5303000.0,-224274000.0,-52619000.0,97480000.0,-144913000.0,,1551957000,en-US,US,EQUITY,True,Nasdaq Real Time Price,USD,2,NYQ,128.33,1630506454,-2.4400024,130.97,130.97,128.33,67701,0,DaVita Inc.,REGULAR,us_market,-1.8658731,128.33 - 130.97,130.77,128.81,128.95,8,9,finmb_35644,NYSE,DaVita Inc.,USD,591603,421883,47.480003,0.5872604,80.85 - 136.48,-8.149994,-0.059715666,80.85,136.48,1619712309,1635332340,1635768000,19.837688,0.015434107,117.63196,10.698044,0.09094504,13.367708,6.469,9.6,9.22,13.918654,11.656,126.37945,1.9505539,13628646400,11.00978,15,America/New_York,EDT,-14400000,False,False,1.27,,,136.48,80.85,126.38,117.63,591.6k,421.88k,106.2M,,101.73M,2.97%,90.28%,2.46M,3.7,3.60%,2.35%,2.25M,,,,,,0.00%,,,2:1,"Sep 08, 2013","Dec 30, 2020","Jun 29, 2021",7.47%,14.98%,5.84%,34.47%,11.57B,103.40,1.30%,3.56B,2.39B,883.3M,6.47,45.70%,1.08B,10.31,12.09B,418.56,1.67,11.66,1.8B,602.51M,Value,80202,Healthcare,67000,9,6,"DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services; vascular access services; clinical research programs; physician services; and comprehensive care services. As of December 31, 2020, it provided dialysis and administrative services in the United States through a network of 2,816 outpatient dialysis centers serving approximately 204,200 patients; and operated 321 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 36,700 patients. Further, the company provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.",Denver,720 631 2100,CO,2,1609372800,1625097600,2,United States,http://www.davita.com,86400,6,2000 16th Street,Medical Care Facilities
t-2,DVA,-5702128000,106200000,,,327371000,1513214000,173773000,304519000,848441000,382436000,382436000,,-59092000,,,,73368000,2905322000,2522886000,2056881000,-55065000,-19633000.0,254003000,173773000,166585000,597073000,14091736000,1383566000,694718000,16988516000,110000,176832000,852537000,959660000,6919109000,-66154000,76830000,324958000,2476143000,133502000,-66154000,6384913000,3148724000,292355000,20101000,2438821000,7678010000,111625000,434253000,-10803000.0,36755000.0,-338064000.0,37398000.0,-465079000.0,-48829000.0,-315547000.0,-437377000.0,2798000.0,484798000.0,161486000.0,-3904000.0,-8682000.0,-65100000.0,161430000.0,-224645000.0,,672581000,en-US,US,EQUITY,True,Nasdaq Real Time Price,USD,2,NYQ,128.33,1630506454,-2.4400024,130.97,130.97,128.33,67701,0,DaVita Inc.,REGULAR,us_market,-1.8658731,128.33 - 130.97,130.77,128.81,128.95,8,9,finmb_35644,NYSE,DaVita Inc.,USD,591603,421883,47.480003,0.5872604,80.85 - 136.48,-8.149994,-0.059715666,80.85,136.48,1619712309,1635332340,1635768000,19.837688,0.015434107,117.63196,10.698044,0.09094504,13.367708,6.469,9.6,9.22,13.918654,11.656,126.37945,1.9505539,13628646400,11.00978,15,America/New_York,EDT,-14400000,False,False,1.27,,,136.48,80.85,126.38,117.63,591.6k,421.88k,106.2M,,101.73M,2.97%,90.28%,2.46M,3.7,3.60%,2.35%,2.25M,,,,,,0.00%,,,2:1,"Sep 08, 2013","Dec 30, 2020","Jun 29, 2021",7.47%,14.98%,5.84%,34.47%,11.57B,103.40,1.30%,3.56B,2.39B,883.3M,6.47,45.70%,1.08B,10.31,12.09B,418.56,1.67,11.66,1.8B,602.51M,Value,80202,Healthcare,67000,9,6,"DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services; vascular access services; clinical research programs; physician services; and comprehensive care services. As of December 31, 2020, it provided dialysis and administrative services in the United States through a network of 2,816 outpatient dialysis centers serving approximately 204,200 patients; and operated 321 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 36,700 patients. Further, the company provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.",Denver,720 631 2100,CO,2,1609372800,1625097600,2,United States,http://www.davita.com,86400,6,2000 16th Street,Medical Care Facilities
t-3,DVA,-5411698000,106200000,,,283332000,1482517000,158674000,363280000,952347000,432173000,432173000,,-72280000,,,,65792000,2924066000,2491893000,1971719000,-148841000,-19633000.0,217540000,158674000,118078000,694132000,13989398000,1574757000,879792000,17046672000,126000,106823000,2031607000,913062000,6868377000,-1151108000,93604000,710514000,2499241000,163787000,-122530000,6252082000,3429675000,284856000,19360000,2428212000,7591934000,106254000,388504000,133667000.0,16303000.0,-80168000.0,-1789532000.0,-2621271000.0,44426000.0,-2218382000.0,-704080000.0,330000.0,482727000.0,156894000.0,-7749000.0,-27599000.0,-131497000.0,237138000.0,-158229000.0,3838000.0,930434000,en-US,US,EQUITY,True,Nasdaq Real Time Price,USD,2,NYQ,128.33,1630506454,-2.4400024,130.97,130.97,128.33,67701,0,DaVita Inc.,REGULAR,us_market,-1.8658731,128.33 - 130.97,130.77,128.81,128.95,8,9,finmb_35644,NYSE,DaVita Inc.,USD,591603,421883,47.480003,0.5872604,80.85 - 136.48,-8.149994,-0.059715666,80.85,136.48,1619712309,1635332340,1635768000,19.837688,0.015434107,117.63196,10.698044,0.09094504,13.367708,6.469,9.6,9.22,13.918654,11.656,126.37945,1.9505539,13628646400,11.00978,15,America/New_York,EDT,-14400000,False,False,1.27,,,136.48,80.85,126.38,117.63,591.6k,421.88k,106.2M,,101.73M,2.97%,90.28%,2.46M,3.7,3.60%,2.35%,2.25M,,,,,,0.00%,,,2:1,"Sep 08, 2013","Dec 30, 2020","Jun 29, 2021",7.47%,14.98%,5.84%,34.47%,11.57B,103.40,1.30%,3.56B,2.39B,883.3M,6.47,45.70%,1.08B,10.31,12.09B,418.56,1.67,11.66,1.8B,602.51M,Value,80202,Healthcare,67000,9,6,"DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services; vascular access services; clinical research programs; physician services; and comprehensive care services. As of December 31, 2020, it provided dialysis and administrative services in the United States through a network of 2,816 outpatient dialysis centers serving approximately 204,200 patients; and operated 321 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 36,700 patients. Further, the company provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.",Denver,720 631 2100,CO,2,1609372800,1625097600,2,United States,http://www.davita.com,86400,6,2000 16th Street,Medical Care Facilities
